8-hydroxy-2-(di-n-propylamino)tetralin and n-methylquipazine

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with n-methylquipazine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S1
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J1

Reviews

1 review(s) available for 8-hydroxy-2-(di-n-propylamino)tetralin and n-methylquipazine

ArticleYear
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
    Journal of medicinal chemistry, 2022, 08-25, Volume: 65, Issue:16

    Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin

2022

Other Studies

1 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and n-methylquipazine

ArticleYear
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5

    Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured

1998